A novel compound (VSC2) has anti-inflammatory and antioxidant properties in microglia and in an animal model of PD by preventing NF-κB activation and the production of TNF-α, iNOS, IL-1β, NO, and COX-2 (Lee et al., 2015). Here, NOS2 is linked to Parkinson disease.